Tatva Chintan Pharma Chem Ltd

TATVA
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹5,866 cr, stock is ranked 474
Moderate RiskStock is 2.86x as volatile as Nifty
2,605.8041.00 (-1.55%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹5,866 cr, stock is ranked 474
Moderate RiskStock is 2.86x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
112.26
PB RatioPB Ratio
35.35
Dividend YieldDiv. Yield
0.17%
Sector PESector PE
25.66
Sector PBSector PB
3.26
Sector Div YldSctr Div Yld
1.51%

Forecast & RatingsDetailed Forecast 

50%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Tatva Chintan Pharma Chem is engaged in the manufacturing business of chemical products.

Investor PresentationView older 

Jan 18, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021137.29207.55264.62306.2912.2820.5437.7852.26
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Monitoring Agency Report 
Announced OnJan 20, 2022

Sub: Submission of Monitoring agency report Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended December 31, 2021, issued by ICICI Bank Limited, appointed to monitor the utilization of proceeds of an Initial Public Offering ( IPO ) of the Company. | Download

Sub: Submission of Monitoring agency report Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended December 31, 2021, issued by ICICI Bank Limited, appointed to monitor the utilization of proceeds of an Initial Public Offering ( IPO ) of the Company. | Download

Statement of deviation(s) or variation(s) under Reg. 32 
Announced OnJan 20, 2022

Tatva Chintan Pharma Chem Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | Download

Tatva Chintan Pharma Chem Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | Download

Investor Presentation 
Announced OnJan 18, 2022

Tatva Chintan Pharma Chem Limited has informed the Exchange about Investor Presentation | Download

Tatva Chintan Pharma Chem Limited has informed the Exchange about Investor Presentation | Download

See all events